

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | dopamine transport (GO:0015872) | 7.14721425 |
| 2 | phenol-containing compound catabolic process (GO:0019336) | 4.79643072 |
| 3 | dopamine biosynthetic process (GO:0042416) | 4.77186177 |
| 4 | sleep (GO:0030431) | 4.37054753 |
| 5 | catecholamine transport (GO:0051937) | 4.27816332 |
| 6 | response to gravity (GO:0009629) | 4.18097801 |
| 7 | DNA deamination (GO:0045006) | 4.07795634 |
| 8 | regulation of endothelial cell differentiation (GO:0045601) | 3.83772558 |
| 9 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 3.70567882 |
| 10 | NADH dehydrogenase complex assembly (GO:0010257) | 3.70567882 |
| 11 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 3.70567882 |
| 12 | cellular response to nicotine (GO:0071316) | 3.61626625 |
| 13 | positive regulation of prostaglandin secretion (GO:0032308) | 3.60437976 |
| 14 | regulation of skeletal muscle contraction (GO:0014819) | 3.51867725 |
| 15 | behavioral response to nicotine (GO:0035095) | 3.50366468 |
| 16 | neurotransmitter biosynthetic process (GO:0042136) | 3.49045222 |
| 17 | protein complex biogenesis (GO:0070271) | 3.48398756 |
| 18 | L-fucose catabolic process (GO:0042355) | 3.43528114 |
| 19 | fucose catabolic process (GO:0019317) | 3.43528114 |
| 20 | L-fucose metabolic process (GO:0042354) | 3.43528114 |
| 21 | water-soluble vitamin biosynthetic process (GO:0042364) | 3.21621824 |
| 22 | phosphorylated carbohydrate dephosphorylation (GO:0046838) | 3.20723129 |
| 23 | inositol phosphate dephosphorylation (GO:0046855) | 3.20723129 |
| 24 | mitochondrial respiratory chain complex assembly (GO:0033108) | 3.11986500 |
| 25 | positive regulation of defense response to virus by host (GO:0002230) | 3.11851459 |
| 26 | catecholamine biosynthetic process (GO:0042423) | 3.08746776 |
| 27 | catechol-containing compound biosynthetic process (GO:0009713) | 3.08746776 |
| 28 | monoamine transport (GO:0015844) | 3.07723987 |
| 29 | cellular response to exogenous dsRNA (GO:0071360) | 3.04581008 |
| 30 | rRNA catabolic process (GO:0016075) | 3.00896786 |
| 31 | positive regulation of endothelial cell differentiation (GO:0045603) | 2.97836569 |
| 32 | regulation of prostaglandin secretion (GO:0032306) | 2.95216569 |
| 33 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 2.93715452 |
| 34 | prenylation (GO:0097354) | 2.92755804 |
| 35 | protein prenylation (GO:0018342) | 2.92755804 |
| 36 | sulfation (GO:0051923) | 2.92159022 |
| 37 | norepinephrine metabolic process (GO:0042415) | 2.91327873 |
| 38 | regulation of germinal center formation (GO:0002634) | 2.89653759 |
| 39 | kynurenine metabolic process (GO:0070189) | 2.89624027 |
| 40 | neurotransmitter metabolic process (GO:0042133) | 2.87978109 |
| 41 | inositol phosphate catabolic process (GO:0071545) | 2.85559703 |
| 42 | alkaloid metabolic process (GO:0009820) | 2.83687799 |
| 43 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.82908031 |
| 44 | detection of calcium ion (GO:0005513) | 2.81164224 |
| 45 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.78413680 |
| 46 | adenosine metabolic process (GO:0046085) | 2.78351249 |
| 47 | response to xenobiotic stimulus (GO:0009410) | 2.77595856 |
| 48 | neuronal action potential (GO:0019228) | 2.75591341 |
| 49 | cytidine metabolic process (GO:0046087) | 2.74859702 |
| 50 | cytidine catabolic process (GO:0006216) | 2.74859702 |
| 51 | cytidine deamination (GO:0009972) | 2.74859702 |
| 52 | tryptophan metabolic process (GO:0006568) | 2.73358428 |
| 53 | endoderm formation (GO:0001706) | 2.72592306 |
| 54 | response to interferon-beta (GO:0035456) | 2.70888027 |
| 55 | detection of chemical stimulus involved in sensory perception of bitter taste (GO:0001580) | 2.70865954 |
| 56 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.70273135 |
| 57 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 2.69778349 |
| 58 | ATP synthesis coupled proton transport (GO:0015986) | 2.69778349 |
| 59 | mannosylation (GO:0097502) | 2.69577665 |
| 60 | positive regulation of fatty acid transport (GO:2000193) | 2.68765038 |
| 61 | respiratory chain complex IV assembly (GO:0008535) | 2.68451953 |
| 62 | regulation of memory T cell differentiation (GO:0043380) | 2.67521936 |
| 63 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 2.65677741 |
| 64 | preassembly of GPI anchor in ER membrane (GO:0016254) | 2.64847329 |
| 65 | positive regulation of tyrosine phosphorylation of Stat5 protein (GO:0042523) | 2.63251443 |
| 66 | tyrosine metabolic process (GO:0006570) | 2.60708173 |
| 67 | benzene-containing compound metabolic process (GO:0042537) | 2.60671083 |
| 68 | indolalkylamine metabolic process (GO:0006586) | 2.60177115 |
| 69 | axoneme assembly (GO:0035082) | 2.55553660 |
| 70 | organic cation transport (GO:0015695) | 2.55496981 |
| 71 | RNA phosphodiester bond hydrolysis, exonucleolytic (GO:0090503) | 2.54925237 |
| 72 | regulation of defense response to virus by host (GO:0050691) | 2.54174023 |
| 73 | L-methionine salvage (GO:0071267) | 2.54142425 |
| 74 | L-methionine biosynthetic process (GO:0071265) | 2.54142425 |
| 75 | amino acid salvage (GO:0043102) | 2.54142425 |
| 76 | regulation of tyrosine phosphorylation of Stat5 protein (GO:0042522) | 2.53530252 |
| 77 | regulation of dopamine metabolic process (GO:0042053) | 2.51417569 |
| 78 | regulation of catecholamine metabolic process (GO:0042069) | 2.51417569 |
| 79 | indole-containing compound catabolic process (GO:0042436) | 2.51022304 |
| 80 | indolalkylamine catabolic process (GO:0046218) | 2.51022304 |
| 81 | tryptophan catabolic process (GO:0006569) | 2.51022304 |
| 82 | interferon-gamma production (GO:0032609) | 2.50723481 |
| 83 | negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244) | 2.49565048 |
| 84 | platelet dense granule organization (GO:0060155) | 2.49526763 |
| 85 | dopamine metabolic process (GO:0042417) | 2.49320419 |
| 86 | mesenchymal cell differentiation involved in kidney development (GO:0072161) | 2.49211033 |
| 87 | mesenchymal cell differentiation involved in renal system development (GO:2001012) | 2.49211033 |
| 88 | electron transport chain (GO:0022900) | 2.49073942 |
| 89 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.48125003 |
| 90 | response to corticosterone (GO:0051412) | 2.44206751 |
| 91 | multicellular organism reproduction (GO:0032504) | 2.43589770 |
| 92 | aromatic amino acid family metabolic process (GO:0009072) | 2.42467957 |
| 93 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 2.42381286 |
| 94 | mitotic cell cycle arrest (GO:0071850) | 2.41473504 |
| 95 | respiratory electron transport chain (GO:0022904) | 2.41435472 |
| 96 | positive regulation of icosanoid secretion (GO:0032305) | 2.41219070 |
| 97 | cellular response to interleukin-15 (GO:0071350) | 2.40124350 |
| 98 | regulation of cilium movement (GO:0003352) | 2.40033213 |
| 99 | negative regulation of intracellular estrogen receptor signaling pathway (GO:0033147) | 2.39017042 |
| 100 | cellular ketone body metabolic process (GO:0046950) | 2.38379948 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 6.27209219 |
| 2 | VDR_22108803_ChIP-Seq_LS180_Human | 3.70448766 |
| 3 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.77676866 |
| 4 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.77514681 |
| 5 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.36993260 |
| 6 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.35524150 |
| 7 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.33243600 |
| 8 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.16046110 |
| 9 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.12499301 |
| 10 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.04551221 |
| 11 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.01341682 |
| 12 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.94804437 |
| 13 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.94501936 |
| 14 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.94228524 |
| 15 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.93060450 |
| 16 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.92191776 |
| 17 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.91645292 |
| 18 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.83895658 |
| 19 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.77363249 |
| 20 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.76126691 |
| 21 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.75424961 |
| 22 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.73749609 |
| 23 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.73550734 |
| 24 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.72701941 |
| 25 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.61563953 |
| 26 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.61206771 |
| 27 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.58882243 |
| 28 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.53016870 |
| 29 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.53016870 |
| 30 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.52969932 |
| 31 | AR_20517297_ChIP-Seq_VCAP_Human | 1.50319936 |
| 32 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.49874672 |
| 33 | GATA3_26560356_Chip-Seq_TH2_Human | 1.48341495 |
| 34 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.42338496 |
| 35 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.41004443 |
| 36 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.41004443 |
| 37 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.39240145 |
| 38 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.38441213 |
| 39 | FUS_26573619_Chip-Seq_HEK293_Human | 1.38055515 |
| 40 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.36381206 |
| 41 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.36254001 |
| 42 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.36191614 |
| 43 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.35100097 |
| 44 | P300_19829295_ChIP-Seq_ESCs_Human | 1.33769926 |
| 45 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.30322583 |
| 46 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.29924632 |
| 47 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.29911964 |
| 48 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.21667551 |
| 49 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.20942060 |
| 50 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.20671920 |
| 51 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.20008806 |
| 52 | HOXB7_26014856_ChIP-Seq_BT474_Human | 1.19903939 |
| 53 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.17617379 |
| 54 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.17439894 |
| 55 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.17021549 |
| 56 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.16431678 |
| 57 | ERG_20517297_ChIP-Seq_VCAP_Human | 1.15558050 |
| 58 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.15109058 |
| 59 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.14827725 |
| 60 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 1.14180630 |
| 61 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.14089454 |
| 62 | AR_25329375_ChIP-Seq_VCAP_Human | 1.13334382 |
| 63 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.13263191 |
| 64 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.12997133 |
| 65 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.12997133 |
| 66 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.12921641 |
| 67 | EWS_26573619_Chip-Seq_HEK293_Human | 1.11129753 |
| 68 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.10438564 |
| 69 | STAT3_23295773_ChIP-Seq_U87_Human | 1.10174273 |
| 70 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.09284538 |
| 71 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.08885135 |
| 72 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.08667336 |
| 73 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 1.07514450 |
| 74 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.06761664 |
| 75 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.06133827 |
| 76 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.05390762 |
| 77 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.04995720 |
| 78 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 1.03997884 |
| 79 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 1.02202048 |
| 80 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.02179180 |
| 81 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.01906452 |
| 82 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.00770762 |
| 83 | TCF4_23295773_ChIP-Seq_U87_Human | 1.00309404 |
| 84 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.00131875 |
| 85 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.00002485 |
| 86 | MYC_19829295_ChIP-Seq_ESCs_Human | 0.99776362 |
| 87 | GATA3_26560356_Chip-Seq_TH1_Human | 0.98388885 |
| 88 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.98114260 |
| 89 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 0.97024280 |
| 90 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 0.96935956 |
| 91 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.96019542 |
| 92 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.95772013 |
| 93 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.95344628 |
| 94 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.94534963 |
| 95 | CJUN_26792858_Chip-Seq_BT549_Human | 0.94375030 |
| 96 | TDRD3_21172665_ChIP-Seq_MCF-7_Human | 0.93405931 |
| 97 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.92462728 |
| 98 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 0.92184670 |
| 99 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.92007239 |
| 100 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.91848802 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0008872_abnormal_physiological_respon | 3.17984933 |
| 2 | MP0002837_dystrophic_cardiac_calcinosis | 2.62170060 |
| 3 | MP0009046_muscle_twitch | 2.54495422 |
| 4 | MP0001905_abnormal_dopamine_level | 2.46283449 |
| 5 | MP0003195_calcinosis | 2.41621979 |
| 6 | MP0003724_increased_susceptibility_to | 2.38049507 |
| 7 | MP0004043_abnormal_pH_regulation | 2.36889000 |
| 8 | MP0006072_abnormal_retinal_apoptosis | 2.36350187 |
| 9 | MP0002876_abnormal_thyroid_physiology | 2.32905074 |
| 10 | MP0005671_abnormal_response_to | 2.29322602 |
| 11 | MP0008875_abnormal_xenobiotic_pharmacok | 2.26250177 |
| 12 | MP0003646_muscle_fatigue | 2.11612967 |
| 13 | MP0002138_abnormal_hepatobiliary_system | 2.05786002 |
| 14 | MP0008775_abnormal_heart_ventricle | 1.97205187 |
| 15 | MP0000465_gastrointestinal_hemorrhage | 1.83892355 |
| 16 | MP0009697_abnormal_copulation | 1.82978556 |
| 17 | MP0004147_increased_porphyrin_level | 1.81269422 |
| 18 | MP0005646_abnormal_pituitary_gland | 1.80644127 |
| 19 | MP0009764_decreased_sensitivity_to | 1.80541950 |
| 20 | MP0002166_altered_tumor_susceptibility | 1.79839987 |
| 21 | MP0004215_abnormal_myocardial_fiber | 1.75971629 |
| 22 | MP0000013_abnormal_adipose_tissue | 1.73897254 |
| 23 | MP0005084_abnormal_gallbladder_morpholo | 1.73848380 |
| 24 | MP0009780_abnormal_chondrocyte_physiolo | 1.73756015 |
| 25 | MP0001835_abnormal_antigen_presentation | 1.66347368 |
| 26 | MP0004145_abnormal_muscle_electrophysio | 1.65268862 |
| 27 | MP0001765_abnormal_ion_homeostasis | 1.57666850 |
| 28 | MP0005253_abnormal_eye_physiology | 1.56116551 |
| 29 | MP0002102_abnormal_ear_morphology | 1.48092208 |
| 30 | MP0000685_abnormal_immune_system | 1.46385569 |
| 31 | MP0002148_abnormal_hypersensitivity_rea | 1.46309033 |
| 32 | MP0005551_abnormal_eye_electrophysiolog | 1.44433107 |
| 33 | MP0002006_tumorigenesis | 1.42876308 |
| 34 | MP0004084_abnormal_cardiac_muscle | 1.41585020 |
| 35 | MP0002163_abnormal_gland_morphology | 1.40844643 |
| 36 | MP0008877_abnormal_DNA_methylation | 1.40207517 |
| 37 | MP0003950_abnormal_plasma_membrane | 1.39870110 |
| 38 | MP0005360_urolithiasis | 1.39597975 |
| 39 | MP0005410_abnormal_fertilization | 1.38317642 |
| 40 | MP0005645_abnormal_hypothalamus_physiol | 1.34907137 |
| 41 | MP0001661_extended_life_span | 1.33776481 |
| 42 | MP0006036_abnormal_mitochondrial_physio | 1.33240616 |
| 43 | MP0005365_abnormal_bile_salt | 1.33213805 |
| 44 | MP0002272_abnormal_nervous_system | 1.32441312 |
| 45 | MP0000569_abnormal_digit_pigmentation | 1.27694554 |
| 46 | MP0005000_abnormal_immune_tolerance | 1.27628224 |
| 47 | MP0005332_abnormal_amino_acid | 1.27087021 |
| 48 | MP0000230_abnormal_systemic_arterial | 1.26676128 |
| 49 | MP0002332_abnormal_exercise_endurance | 1.26635146 |
| 50 | MP0003786_premature_aging | 1.25509821 |
| 51 | MP0010329_abnormal_lipoprotein_level | 1.24956585 |
| 52 | MP0001968_abnormal_touch/_nociception | 1.24862243 |
| 53 | MP0001800_abnormal_humoral_immune | 1.22614897 |
| 54 | MP0002638_abnormal_pupillary_reflex | 1.20929743 |
| 55 | MP0004484_altered_response_of | 1.19119172 |
| 56 | MP0005085_abnormal_gallbladder_physiolo | 1.17990344 |
| 57 | MP0001501_abnormal_sleep_pattern | 1.17337089 |
| 58 | MP0003252_abnormal_bile_duct | 1.17135844 |
| 59 | MP0001986_abnormal_taste_sensitivity | 1.15470476 |
| 60 | MP0002009_preneoplasia | 1.12236765 |
| 61 | MP0005636_abnormal_mineral_homeostasis | 1.11274965 |
| 62 | MP0004142_abnormal_muscle_tone | 1.10801600 |
| 63 | MP0001879_abnormal_lymphatic_vessel | 1.09959767 |
| 64 | MP0002723_abnormal_immune_serum | 1.09447123 |
| 65 | MP0002736_abnormal_nociception_after | 1.06252114 |
| 66 | MP0001756_abnormal_urination | 1.05017847 |
| 67 | MP0006276_abnormal_autonomic_nervous | 1.03016746 |
| 68 | MP0002452_abnormal_antigen_presenting | 1.00801950 |
| 69 | MP0009745_abnormal_behavioral_response | 1.00502988 |
| 70 | MP0000427_abnormal_hair_cycle | 1.00068509 |
| 71 | MP0005379_endocrine/exocrine_gland_phen | 0.99932547 |
| 72 | MP0009643_abnormal_urine_homeostasis | 0.99798491 |
| 73 | MP0009785_altered_susceptibility_to | 0.98525522 |
| 74 | MP0005165_increased_susceptibility_to | 0.98348219 |
| 75 | MP0010386_abnormal_urinary_bladder | 0.97868929 |
| 76 | MP0004885_abnormal_endolymph | 0.97059975 |
| 77 | MP0005167_abnormal_blood-brain_barrier | 0.96550375 |
| 78 | MP0005389_reproductive_system_phenotype | 0.96414388 |
| 79 | MP0003806_abnormal_nucleotide_metabolis | 0.95882727 |
| 80 | MP0004036_abnormal_muscle_relaxation | 0.95278165 |
| 81 | MP0000749_muscle_degeneration | 0.93823679 |
| 82 | MP0001873_stomach_inflammation | 0.92474379 |
| 83 | MP0002693_abnormal_pancreas_physiology | 0.90867038 |
| 84 | MP0003763_abnormal_thymus_physiology | 0.90484218 |
| 85 | MP0001790_abnormal_immune_system | 0.89272754 |
| 86 | MP0005387_immune_system_phenotype | 0.89272754 |
| 87 | MP0005670_abnormal_white_adipose | 0.89091063 |
| 88 | MP0002139_abnormal_hepatobiliary_system | 0.85850884 |
| 89 | MP0001845_abnormal_inflammatory_respons | 0.84754989 |
| 90 | MP0003718_maternal_effect | 0.84039199 |
| 91 | MP0001819_abnormal_immune_cell | 0.82681384 |
| 92 | MP0003436_decreased_susceptibility_to | 0.82552831 |
| 93 | MP0003866_abnormal_defecation | 0.82337589 |
| 94 | MP0010368_abnormal_lymphatic_system | 0.80806989 |
| 95 | MP0000372_irregular_coat_pigmentation | 0.80593349 |
| 96 | MP0003183_abnormal_peptide_metabolism | 0.80589638 |
| 97 | MP0002420_abnormal_adaptive_immunity | 0.79741125 |
| 98 | MP0002972_abnormal_cardiac_muscle | 0.77276446 |
| 99 | MP0003638_abnormal_response/metabolism_ | 0.75530402 |
| 100 | MP0000750_abnormal_muscle_regeneration | 0.73058190 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Limb dystonia (HP:0002451) | 4.57303924 |
| 2 | Decreased circulating renin level (HP:0003351) | 4.11064308 |
| 3 | Tongue fasciculations (HP:0001308) | 4.04174429 |
| 4 | Renal cortical cysts (HP:0000803) | 3.73156579 |
| 5 | Lipid accumulation in hepatocytes (HP:0006561) | 3.47595737 |
| 6 | Muscle fibrillation (HP:0010546) | 3.44610804 |
| 7 | Congenital, generalized hypertrichosis (HP:0004540) | 3.43770494 |
| 8 | Abnormality of the renal cortex (HP:0011035) | 3.32177490 |
| 9 | Mitochondrial inheritance (HP:0001427) | 3.20946737 |
| 10 | Increased hepatocellular lipid droplets (HP:0006565) | 3.14929734 |
| 11 | Hepatic necrosis (HP:0002605) | 3.12534977 |
| 12 | Hepatocellular necrosis (HP:0001404) | 3.10841331 |
| 13 | Type II lissencephaly (HP:0007260) | 3.02809306 |
| 14 | Increased CSF lactate (HP:0002490) | 2.96031628 |
| 15 | IgG deficiency (HP:0004315) | 2.82274464 |
| 16 | Hypothermia (HP:0002045) | 2.80821881 |
| 17 | Hypokinesia (HP:0002375) | 2.77867572 |
| 18 | Abnormal drinking behavior (HP:0030082) | 2.77283931 |
| 19 | Polydipsia (HP:0001959) | 2.77283931 |
| 20 | Abnormality of renin-angiotensin system (HP:0000847) | 2.67531761 |
| 21 | Oral leukoplakia (HP:0002745) | 2.65231423 |
| 22 | Absent/shortened dynein arms (HP:0200106) | 2.59527838 |
| 23 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.59527838 |
| 24 | Renal Fanconi syndrome (HP:0001994) | 2.52012712 |
| 25 | Pancreatic cysts (HP:0001737) | 2.50928137 |
| 26 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.49635984 |
| 27 | Abnormality of alanine metabolism (HP:0010916) | 2.49635984 |
| 28 | Hyperalaninemia (HP:0003348) | 2.49635984 |
| 29 | Exertional dyspnea (HP:0002875) | 2.48271216 |
| 30 | Abnormality of urine glucose concentration (HP:0011016) | 2.46013735 |
| 31 | Glycosuria (HP:0003076) | 2.46013735 |
| 32 | Nephronophthisis (HP:0000090) | 2.44399006 |
| 33 | Fibular aplasia (HP:0002990) | 2.43452636 |
| 34 | Delayed gross motor development (HP:0002194) | 2.41280894 |
| 35 | Increased intramyocellular lipid droplets (HP:0012240) | 2.39950869 |
| 36 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.39270726 |
| 37 | Acute necrotizing encephalopathy (HP:0006965) | 2.38880282 |
| 38 | 3-Methylglutaconic aciduria (HP:0003535) | 2.37790865 |
| 39 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.37608865 |
| 40 | Increased serum lactate (HP:0002151) | 2.36734151 |
| 41 | Molar tooth sign on MRI (HP:0002419) | 2.34826829 |
| 42 | Abnormality of midbrain morphology (HP:0002418) | 2.34826829 |
| 43 | Increased muscle lipid content (HP:0009058) | 2.33277783 |
| 44 | Congenital stationary night blindness (HP:0007642) | 2.28458909 |
| 45 | Stomatitis (HP:0010280) | 2.27346024 |
| 46 | Stomach cancer (HP:0012126) | 2.23166231 |
| 47 | Abnormality of the renal medulla (HP:0100957) | 2.20286773 |
| 48 | Pancreatic fibrosis (HP:0100732) | 2.18998906 |
| 49 | Palpitations (HP:0001962) | 2.16801119 |
| 50 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.16713353 |
| 51 | Delayed CNS myelination (HP:0002188) | 2.15864624 |
| 52 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.15143645 |
| 53 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.12530208 |
| 54 | Aplasia/hypoplasia of the uterus (HP:0008684) | 2.11964748 |
| 55 | Pustule (HP:0200039) | 2.11066359 |
| 56 | Hypoplasia of the uterus (HP:0000013) | 2.10041525 |
| 57 | Lactic acidosis (HP:0003128) | 2.09668351 |
| 58 | Progressive macrocephaly (HP:0004481) | 2.08538504 |
| 59 | Polyuria (HP:0000103) | 2.08466525 |
| 60 | Dyskinesia (HP:0100660) | 2.07442363 |
| 61 | Abolished electroretinogram (ERG) (HP:0000550) | 2.07105977 |
| 62 | Short tibia (HP:0005736) | 2.05582100 |
| 63 | Late onset (HP:0003584) | 2.05096369 |
| 64 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.04725716 |
| 65 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.04725716 |
| 66 | Hypoplasia of the fovea (HP:0007750) | 2.02111956 |
| 67 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 2.02111956 |
| 68 | Anomalous pulmonary venous return (HP:0010772) | 2.02054910 |
| 69 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 2.01474766 |
| 70 | Severe muscular hypotonia (HP:0006829) | 2.01448896 |
| 71 | Acute encephalopathy (HP:0006846) | 2.01438912 |
| 72 | Metabolic alkalosis (HP:0200114) | 2.00584020 |
| 73 | Methylmalonic acidemia (HP:0002912) | 1.97593531 |
| 74 | Chronic hepatic failure (HP:0100626) | 1.95200078 |
| 75 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 1.94792471 |
| 76 | Abnormality of the fovea (HP:0000493) | 1.92079534 |
| 77 | Insulin-resistant diabetes mellitus (HP:0000831) | 1.91356967 |
| 78 | Alkalosis (HP:0001948) | 1.90144032 |
| 79 | True hermaphroditism (HP:0010459) | 1.89443070 |
| 80 | Abnormality of the pons (HP:0007361) | 1.88934398 |
| 81 | Hypokalemic alkalosis (HP:0001949) | 1.88124478 |
| 82 | Large for gestational age (HP:0001520) | 1.86823935 |
| 83 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.83253171 |
| 84 | Abnormal urine output (HP:0012590) | 1.83130836 |
| 85 | Constricted visual fields (HP:0001133) | 1.82513434 |
| 86 | Methylmalonic aciduria (HP:0012120) | 1.82467131 |
| 87 | Syncope (HP:0001279) | 1.81454821 |
| 88 | Respiratory failure (HP:0002878) | 1.78530200 |
| 89 | Fair hair (HP:0002286) | 1.77881686 |
| 90 | Prostate neoplasm (HP:0100787) | 1.76913489 |
| 91 | Amelogenesis imperfecta (HP:0000705) | 1.76644849 |
| 92 | Medial flaring of the eyebrow (HP:0010747) | 1.74967900 |
| 93 | Abnormality of T cell physiology (HP:0011840) | 1.73546846 |
| 94 | Hypomagnesemia (HP:0002917) | 1.72438158 |
| 95 | Ketoacidosis (HP:0001993) | 1.69733984 |
| 96 | Abnormality of renal excretion (HP:0011036) | 1.68403149 |
| 97 | Abnormality of the prostate (HP:0008775) | 1.68319335 |
| 98 | Calf muscle hypertrophy (HP:0008981) | 1.68145650 |
| 99 | Clumsiness (HP:0002312) | 1.67498750 |
| 100 | Abnormality of the pulmonary veins (HP:0011718) | 1.66765058 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TLK1 | 4.36534806 |
| 2 | TAOK3 | 4.27280652 |
| 3 | BLK | 3.52844208 |
| 4 | ZAK | 3.11574574 |
| 5 | FRK | 2.87383593 |
| 6 | MAP4K2 | 2.65195782 |
| 7 | MAPKAPK5 | 2.39717040 |
| 8 | MST4 | 2.38215729 |
| 9 | PHKG2 | 2.33369334 |
| 10 | PHKG1 | 2.33369334 |
| 11 | PINK1 | 2.25639515 |
| 12 | TXK | 2.14899262 |
| 13 | ADRBK2 | 1.83975741 |
| 14 | WNK4 | 1.82605128 |
| 15 | MAPKAPK3 | 1.82069008 |
| 16 | NUAK1 | 1.80015415 |
| 17 | MAP3K12 | 1.74319605 |
| 18 | CSNK1G3 | 1.70293846 |
| 19 | BUB1 | 1.67092547 |
| 20 | GRK5 | 1.61990923 |
| 21 | BCKDK | 1.58506875 |
| 22 | BMPR1B | 1.56393496 |
| 23 | GRK1 | 1.54892149 |
| 24 | MAP2K7 | 1.52698904 |
| 25 | STK39 | 1.51042523 |
| 26 | VRK2 | 1.49441404 |
| 27 | GRK6 | 1.45664316 |
| 28 | LIMK1 | 1.44603033 |
| 29 | TESK2 | 1.40433941 |
| 30 | CSNK1G2 | 1.40289260 |
| 31 | CSNK1G1 | 1.39822566 |
| 32 | MAP3K4 | 1.39540313 |
| 33 | OXSR1 | 1.37485540 |
| 34 | VRK1 | 1.27820497 |
| 35 | CAMKK2 | 1.17412768 |
| 36 | MYLK | 1.15672388 |
| 37 | DAPK2 | 1.14198752 |
| 38 | MAP2K2 | 1.10359065 |
| 39 | TRPM7 | 1.06040067 |
| 40 | IKBKB | 1.05095865 |
| 41 | ACVR1B | 0.97028509 |
| 42 | OBSCN | 0.94538054 |
| 43 | RPS6KA5 | 0.93599823 |
| 44 | SYK | 0.91776624 |
| 45 | BMPR2 | 0.90703591 |
| 46 | IKBKE | 0.87494548 |
| 47 | EIF2AK2 | 0.87262581 |
| 48 | PTK2B | 0.87144721 |
| 49 | GRK7 | 0.87077384 |
| 50 | INSRR | 0.86569050 |
| 51 | WNK3 | 0.85646728 |
| 52 | STK16 | 0.81355987 |
| 53 | CAMK2D | 0.78119524 |
| 54 | DAPK1 | 0.76454335 |
| 55 | TBK1 | 0.75151503 |
| 56 | CSNK1A1L | 0.75083562 |
| 57 | SCYL2 | 0.74563666 |
| 58 | TESK1 | 0.74023326 |
| 59 | ERBB3 | 0.70036961 |
| 60 | MAP3K14 | 0.67937728 |
| 61 | TEC | 0.66255860 |
| 62 | ADRBK1 | 0.63949632 |
| 63 | BRSK2 | 0.62302924 |
| 64 | NEK1 | 0.59796817 |
| 65 | MUSK | 0.59493550 |
| 66 | ITK | 0.59252971 |
| 67 | LMTK2 | 0.59049173 |
| 68 | HIPK2 | 0.58487544 |
| 69 | TIE1 | 0.58016963 |
| 70 | CDK8 | 0.57817089 |
| 71 | MAPK13 | 0.56604212 |
| 72 | CAMK2A | 0.55051780 |
| 73 | PLK2 | 0.52245612 |
| 74 | PRKCE | 0.51942175 |
| 75 | PAK3 | 0.51377323 |
| 76 | EPHA3 | 0.49275392 |
| 77 | FES | 0.48673315 |
| 78 | PIK3CA | 0.48639518 |
| 79 | PRKAA2 | 0.47424541 |
| 80 | CAMK2G | 0.47422170 |
| 81 | MAP3K11 | 0.43548653 |
| 82 | FER | 0.39779931 |
| 83 | EIF2AK3 | 0.39575457 |
| 84 | WNK1 | 0.35736372 |
| 85 | CAMK2B | 0.35553957 |
| 86 | LYN | 0.35131570 |
| 87 | MAP2K6 | 0.33869777 |
| 88 | PIM1 | 0.33737553 |
| 89 | IGF1R | 0.33195278 |
| 90 | ABL2 | 0.31869127 |
| 91 | PRKCQ | 0.31775268 |
| 92 | TGFBR2 | 0.30658160 |
| 93 | KDR | 0.29537951 |
| 94 | PDK2 | 0.28764852 |
| 95 | PRKACA | 0.28602851 |
| 96 | MAPKAPK2 | 0.28550442 |
| 97 | PRKCI | 0.28133390 |
| 98 | CSNK1A1 | 0.26766367 |
| 99 | CHUK | 0.26477255 |
| 100 | PRKCA | 0.26304901 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Sulfur metabolism_Homo sapiens_hsa00920 | 3.16520288 |
| 2 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 3.03754156 |
| 3 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.73720267 |
| 4 | Parkinsons disease_Homo sapiens_hsa05012 | 2.72985194 |
| 5 | Asthma_Homo sapiens_hsa05310 | 2.42143648 |
| 6 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 2.00706784 |
| 7 | Proteasome_Homo sapiens_hsa03050 | 1.95540841 |
| 8 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.86636847 |
| 9 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.78144859 |
| 10 | Allograft rejection_Homo sapiens_hsa05330 | 1.76344394 |
| 11 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.74329646 |
| 12 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.71504002 |
| 13 | Salivary secretion_Homo sapiens_hsa04970 | 1.70332809 |
| 14 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.67739594 |
| 15 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.67442208 |
| 16 | RNA polymerase_Homo sapiens_hsa03020 | 1.65784338 |
| 17 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.63847643 |
| 18 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.62887736 |
| 19 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.62193224 |
| 20 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.60051787 |
| 21 | Alzheimers disease_Homo sapiens_hsa05010 | 1.55744250 |
| 22 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.54497250 |
| 23 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.52806866 |
| 24 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.51194815 |
| 25 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.46994281 |
| 26 | Huntingtons disease_Homo sapiens_hsa05016 | 1.43116534 |
| 27 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.42648349 |
| 28 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.40988022 |
| 29 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.38362509 |
| 30 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.29059700 |
| 31 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.28789328 |
| 32 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.28448144 |
| 33 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.27228150 |
| 34 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.25890050 |
| 35 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.24574589 |
| 36 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.19639632 |
| 37 | Protein export_Homo sapiens_hsa03060 | 1.16760459 |
| 38 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.14256543 |
| 39 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.13673937 |
| 40 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.13576957 |
| 41 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.13184899 |
| 42 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.11039501 |
| 43 | Phototransduction_Homo sapiens_hsa04744 | 1.09407219 |
| 44 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.08483301 |
| 45 | Insulin secretion_Homo sapiens_hsa04911 | 1.07632103 |
| 46 | Homologous recombination_Homo sapiens_hsa03440 | 1.05792762 |
| 47 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.04970666 |
| 48 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.04813216 |
| 49 | Peroxisome_Homo sapiens_hsa04146 | 1.04258923 |
| 50 | RNA degradation_Homo sapiens_hsa03018 | 1.01104839 |
| 51 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.00348977 |
| 52 | Circadian rhythm_Homo sapiens_hsa04710 | 0.98961226 |
| 53 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.97800652 |
| 54 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.97249572 |
| 55 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.94833576 |
| 56 | Purine metabolism_Homo sapiens_hsa00230 | 0.94211393 |
| 57 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.93355763 |
| 58 | Morphine addiction_Homo sapiens_hsa05032 | 0.90092539 |
| 59 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.89646094 |
| 60 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.89166718 |
| 61 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.87413289 |
| 62 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.86229798 |
| 63 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.84431823 |
| 64 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.81837524 |
| 65 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.81757297 |
| 66 | Olfactory transduction_Homo sapiens_hsa04740 | 0.80520156 |
| 67 | Cocaine addiction_Homo sapiens_hsa05030 | 0.79871061 |
| 68 | Sulfur relay system_Homo sapiens_hsa04122 | 0.76919989 |
| 69 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.73059169 |
| 70 | Basal transcription factors_Homo sapiens_hsa03022 | 0.70016378 |
| 71 | Retinol metabolism_Homo sapiens_hsa00830 | 0.68033102 |
| 72 | Mineral absorption_Homo sapiens_hsa04978 | 0.64985431 |
| 73 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.63923975 |
| 74 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.63346797 |
| 75 | Renin secretion_Homo sapiens_hsa04924 | 0.62049657 |
| 76 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.60342072 |
| 77 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.58461763 |
| 78 | Metabolic pathways_Homo sapiens_hsa01100 | 0.58396832 |
| 79 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.58060210 |
| 80 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.58050718 |
| 81 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.57618021 |
| 82 | ABC transporters_Homo sapiens_hsa02010 | 0.54177204 |
| 83 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.54106149 |
| 84 | Circadian entrainment_Homo sapiens_hsa04713 | 0.53870363 |
| 85 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.53688521 |
| 86 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.53684191 |
| 87 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.49644334 |
| 88 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.49092716 |
| 89 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.48001907 |
| 90 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.47709705 |
| 91 | Taste transduction_Homo sapiens_hsa04742 | 0.46665411 |
| 92 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.46102105 |
| 93 | Alcoholism_Homo sapiens_hsa05034 | 0.45024251 |
| 94 | Viral myocarditis_Homo sapiens_hsa05416 | 0.44632920 |
| 95 | Nicotine addiction_Homo sapiens_hsa05033 | 0.44189774 |
| 96 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.43368054 |
| 97 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.43008004 |
| 98 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.40025679 |
| 99 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.38127942 |
| 100 | GABAergic synapse_Homo sapiens_hsa04727 | 0.36905680 |

